LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

LLY

765.39

+2.52%↑

JNJ

176.33

-0.45%↓

ABBV

216.67

+0.17%↑

UNH

341.11

-2.21%↓

AZN

77.87

-0.12%↓

Search

Dynavax Technologies Corp

Aperta

SettoreSettore sanitario

9.63 3.88

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

9.2

Massimo

9.69

Metriche Chiave

By Trading Economics

Entrata

115M

19M

Vendite

27M

95M

P/E

Media del settore

58.75

35.664

Margine di Profitto

19.615

Dipendenti

405

EBITDA

119M

25M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+140.91% upside

Dividendi

By Dow Jones

Utili prossimi

6 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-201M

1.1B

Apertura precedente

5.75

Chiusura precedente

9.63

Notizie sul Sentiment di mercato

By Acuity

32%

68%

106 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

Dynavax Technologies Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 set 2025, 22:39 UTC

Acquisizioni, Fusioni, Takeovers

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 set 2025, 16:43 UTC

I principali Market Mover

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 set 2025, 16:42 UTC

I principali Market Mover

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 set 2025, 16:35 UTC

I principali Market Mover

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 set 2025, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 23:46 UTC

Discorsi di Mercato

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 set 2025, 23:34 UTC

Discorsi di Mercato

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 set 2025, 22:48 UTC

Discorsi di Mercato

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Expects Commercial Launch in 2029

15 set 2025, 22:12 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 set 2025, 22:11 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 set 2025, 22:10 UTC

Acquisizioni, Fusioni, Takeovers

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 set 2025, 21:16 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 set 2025, 21:15 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 set 2025, 21:14 UTC

Acquisizioni, Fusioni, Takeovers

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 set 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

15 set 2025, 19:29 UTC

Discorsi di Mercato

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 set 2025, 19:14 UTC

Discorsi di Mercato

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 set 2025, 18:16 UTC

Discorsi di Mercato

Gold Powers to New High -- Market Talk

15 set 2025, 18:05 UTC

Discorsi di Mercato

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 set 2025, 17:50 UTC

Acquisizioni, Fusioni, Takeovers

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 set 2025, 17:10 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

15 set 2025, 17:10 UTC

Discorsi di Mercato

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 set 2025, 16:52 UTC

Discorsi di Mercato

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato

Financial Services Roundup: Market Talk

15 set 2025, 16:20 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

Confronto tra pari

Modifica del prezzo

Dynavax Technologies Corp Previsione

Obiettivo di Prezzo

By TipRanks

140.91% in crescita

Previsioni per 12 mesi

Media 22.67 USD  140.91%

Alto 32 USD

Basso 11 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Dynavax Technologies Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

3

Acquista

0

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

9.62 / 10.9Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Very Strong Bearish Evidence

A lungo termine

Strong Bearish Evidence

Sentiment

By Acuity

106 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
help-icon Live chat